These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16481165)

  • 1. Structure-activity relationship of thiopyrimidines as mGluR5 antagonists.
    Hammerland LG; Johansson M; Malmström J; Mattsson JP; Minidis AB; Nilsson K; Peterson A; Wensbo D; Wållberg A; Osterlund K
    Bioorg Med Chem Lett; 2006 May; 16(9):2467-9. PubMed ID: 16481165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5).
    Bach P; Nilsson K; Svensson T; Bauer U; Hammerland LG; Peterson A; Wållberg A; Osterlund K; Karis D; Boije M; Wensbo D
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4788-91. PubMed ID: 16837196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists.
    Baxter A; Cooper A; Kinchin E; Moakes K; Unitt J; Wallace A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):960-3. PubMed ID: 16297626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction.
    Carroll FI
    Ann N Y Acad Sci; 2008 Oct; 1141():221-32. PubMed ID: 18991960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonists.
    Kulkarni SS; Nightingale B; Dersch CM; Rothman RB; Newman AH
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3371-5. PubMed ID: 16678408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents.
    Slee DH; Chen Y; Zhang X; Moorjani M; Lanier MC; Lin E; Rueter JK; Williams JP; Lechner SM; Markison S; Malany S; Santos M; Gross RS; Jalali K; Sai Y; Zuo Z; Yang C; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J
    J Med Chem; 2008 Mar; 51(6):1719-29. PubMed ID: 18307292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
    Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptor.
    Hu E; Chua PC; Tehrani L; Nagasawa JY; Pinkerton AB; Rowe BA; Vernier JM; Hutchinson JH; Cosford ND
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5071-4. PubMed ID: 15380201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5).
    Bach P; Nilsson K; Wållberg A; Bauer U; Hammerland LG; Peterson A; Svensson T; Osterlund K; Karis D; Boije M; Wensbo D
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4792-5. PubMed ID: 16839764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships.
    Slee DH; Moorjani M; Zhang X; Lin E; Lanier MC; Chen Y; Rueter JK; Lechner SM; Markison S; Malany S; Joswig T; Santos M; Gross RS; Williams JP; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Jalali K; Sai Y; Zuo Z; Yang C; Wen J; O'Brien Z; Petroski R; Saunders J
    J Med Chem; 2008 Mar; 51(6):1730-9. PubMed ID: 18307293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
    Serby MD; Zhao H; Szczepankiewicz BG; Kosogof C; Xin Z; Liu B; Liu M; Nelson LT; Kaszubska W; Falls HD; Schaefer V; Bush EN; Shapiro R; Droz BA; Knourek-Segel VE; Fey TA; Brune ME; Beno DW; Turner TM; Collins CA; Jacobson PB; Sham HL; Liu G
    J Med Chem; 2006 Apr; 49(8):2568-78. PubMed ID: 16610800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain.
    Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Li C; Heimark L; Pramanik B; Grilli M; Bertorelli R; Lozza G; Reggiani A
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3199-203. PubMed ID: 19433355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenyl ureas of creatinine as mGluR5 antagonists. A structure-activity relationship study of fenobam analogues.
    Wållberg A; Nilsson K; Osterlund K; Peterson A; Elg S; Raboisson P; Bauer U; Hammerland LG; Mattsson JP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1142-5. PubMed ID: 16380255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
    Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
    J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the development of allosteric modulators of mGluR5.
    Rodriguez AL; Williams R
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity.
    Spanka C; Glatthar R; Desrayaud S; Fendt M; Orain D; Troxler T; Vranesic I
    Bioorg Med Chem Lett; 2010 Jan; 20(1):184-8. PubMed ID: 19931453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models.
    Kohara A; Nagakura Y; Kiso T; Toya T; Watabiki T; Tamura S; Shitaka Y; Itahana H; Okada M
    Eur J Pharmacol; 2007 Sep; 571(1):8-16. PubMed ID: 17597604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists.
    Bonnefous C; Vernier JM; Hutchinson JH; Chung J; Reyes-Manalo G; Kamenecka T
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1197-200. PubMed ID: 15686941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 1,2,4-methyltriazines as mGluR5 antagonists.
    Olson JP; Gichinga MG; Butala E; Navarro HA; Gilmour BP; Carroll FI
    Org Biomol Chem; 2011 Jun; 9(11):4276-86. PubMed ID: 21503289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists.
    Zheng GZ; Bhatia P; Kolasa T; Patel M; El Kouhen OF; Chang R; Uchic ME; Miller L; Baker S; Lehto SG; Honore P; Wetter JM; Marsh KC; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4936-40. PubMed ID: 16809035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.